ACHE and early-onset autosomal dominant Alzheimer disease: One of the principal therapeutic strategies for managing Alzheimer’s disease involves the use of acetylcholinesterase (AChE) inhibitors, which aim to prevent the breakdown of acetylcholine, thereby enhancing cholinergic transmission and alleviating symptoms associated with cognitive impairment [1,2,3].